Studies showed that CB1 exerts proinflammatory and profibrotic effect in pulmonary fibrosis [299,300] and peripherally restricted dual inhibitor of CB1 and iNOS, MRI-1867 (10 mg/kg/day), partially attenuated fibrosis in rodent models [301]. This evidence concerns the gene NOS2 and pulmonary fibrosis.